Cough, cold and sore throat treatments OTC sales value in Great Britain 2009-2023

The sales value of over-the-counter (OTC) cough, cold and sore throat treatments in Great Britain stood at over 583 million British pounds in 2023. This was the highest value in the provided time interval and represented a two percent increase compared to the previous year. OTC medicine market in Great Britain Cough, cold and sore throat medication had the second highest sales value in 2023, when broken down by OTC drug categories. Pain relief medication was the category with the highest sales value, at approximately 750 million British pounds. Vitamins and minerals had a sales value of 492 million British pounds, the third highest category overall in Great Britain. Overall, the sales value of OTC drugs has increased from 1.65 billion British pounds in the year 2000 to approximately 3.2 billion British pounds in 2023.  Growth of other OTC categoriesThe OTC product category which had the highest growth of sales value in Great Britain from 2022 and 2023 was eye care with a significant growth of 13 percent. This was followed by skin treatments which grew by 11 percent compared to the previous year.

2023年，英国非处方（OTC）止咳、感冒及咽喉炎治疗药品的销售价值高达5.83亿英镑。这一数字为所提供时间段内的最高值，与上一年相比增长了百分之二。在英国OTC药品市场中，止咳、感冒及咽喉炎药品在2023年的销售额位居第二，按OTC药品类别划分。销售额最高的类别为镇痛药品，约为7.5亿英镑。维生素及矿物质类药品的销售额为4.92亿英镑，位列英国总体药品类别中的第三。总体而言，自2000年的16.5亿英镑增长至2023年的约32亿英镑，OTC药品的销售价值呈现出显著增长趋势。从2022年至2023年，英国OTC产品类别中销售价值增长最快的是眼科护理，增长了13%，紧随其后的是皮肤治疗，其增长率较上年同期提高了11%。